Evaluation of Locomotor Activity Before and After Total Hip Replacement in Patients With Hip Osteoarthritis.
NCT ID: NCT02042586
Last Updated: 2019-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
202 participants
OBSERVATIONAL
2010-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To this end, the study will take place as follows:
Step 1: Screening, and inclusion. Step 2: Evaluation of the hip osteoarthritis and analysis of locomotor activity Step 3: Total hip replacement Step 4: Clinical evaluation of locomotor activity carried out between 6 months and 1 year after the THR Step 5: Data analysis
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adaptation of Locomotor Activity in Patients Suffering From Hip OA - Analysis of This Adaptation as a Prognostic Criterion for Future Disease Progression
NCT01907503
Development and Pre-validation of a Machine Learning-based Prediction Algorithm for Early Functional Recovery in Patients Undergoing Hip and Knee Replacement Surgery
NCT07333560
The Effectiveness of Rehabilitation in Gait Recovery After Knee or Hip Arthroplasty
NCT04803578
Mobility Assessment of Patients With Total Hip Arthroplasty
NCT00664508
Evaluation of Proprioception in Patients With Total Hip Replacement
NCT05763368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Analysis of movement before total hip replacement
Analysis of movement after total hip replacement
Controls
Analysis of movement before total hip replacement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analysis of movement before total hip replacement
Analysis of movement after total hip replacement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who have provided written informed consent
* Subjects covered by the national health insurance scheme
* Men or women aged between 25 and 85 years
* able to understand simple instructions and packaging instructions and able to give informed consent
Patients group:
* Patients who have provided written informed consent
* Patients covered by the national health insurance scheme
* Men or women aged between 25 and 85 years
* able to understand simple instructions and packaging instructions and to give their informed consent
* Suffering from hip osteoarthritis defined according to ACR criteria
* Most recent radiography examination less than 6 months earlier
* Radiological stage II, III or IV hip osteoarthritis according to the Kellgren and Lawrence classification
* Presenting with an indication for total hip replacement, according to the surgeon's usual criteria
Exclusion Criteria
* Hip osteoarthritis or other arthrosis in the lower limbs
* Pregnant or breast-feeding women
* Disorders that may interfere with gait analysis
* Disorder that may be destabilized by gait analysis
* Neurological disease and/or motor neuron disease
Patients group:
* Contra-indication for total hip replacement
* Repeat surgery for total hip replacement
* Impossibility to use a standard implant
* Pregnant or breast-feeding women
* Inflammatory flare of the hip osteoarthritis
* Disorder that may interfere with gait analysis
* Disorder that may be destabilized by gait analysis
* Rapidly destructive hip osteoarthritis
* Neurological disease and/or motor neuron disease
* Hip dysplasia requiring THR to be completed using a graft
25 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de DIJON
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Riglet L, Bourredjem A, Laroche D, Benguella L, Binquet C, Maillefert JF, Ornetti P, Gueugnon M. Hip disability and Osteoarthritis Outcome Score trajectories and prognostic factors for functional decline: A 3-year follow-up study. Ann Phys Rehabil Med. 2025 Feb;68(1):101893. doi: 10.1016/j.rehab.2024.101893. Epub 2024 Dec 9.
Moissenet F, Naaim A, Ornetti P, Bourredjem A, Binquet C, Morisset C, Gouteron A, Maillefert JF, Laroche D. Is the Pelvis-Thorax Coordination a Valuable Outcome Instrument to Assess Patients With Hip Osteoarthritis? Front Bioeng Biotechnol. 2020 Jan 23;7:457. doi: 10.3389/fbioe.2019.00457. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TROUILLOUD AOI 2007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.